title: Retinoic acid inhibits the expression of cytidine deaminase linked to the differentiation of the human leukemic cell line HL-60.
abstract: The activity of cytidine deaminase markedly increases during the differentiation of HL-60 cells induced by dimethylsulfoxide or 1,25-dihydroxy vitamin D3, but does not increase when the inducer is retinoic acid. Here it is demonstrated that retinoic acid inhibits the increase in cytidine deaminase activity elicited by the other two inducers. This inhibitory effect of retinoic acid (i) was not the result of a direct action on the enzymatic activity; (ii) was correlated with the differentiating effect of retinoic acid, as indicated by the similar time-course and dose-dependence of both effects, and by additional studies with various retinoids and with an HL-60 variant resistant to retinoic acid-induced differentiation; (iii) required the continued presence of the drug for more than 24 h, and could not be reversed after 48 h; (iv) was manifest, after a lag-time of 24 h, at whatever time retinoic acid was added during the 5 days of treatment of the cells with the differentiation inducers; and (v) was prevented by the addition of the protein synthesis inhibitor cycloheximide. These data indicate that retinoic acid negatively regulates the expression of cytidine deaminase in HL-60 cells, and suggest that this effect is mediated by a protein, the synthesis of which should be controlled by the nuclear receptor of retinoic acid.
authors.affiliation: Laboratoire de Biochimie, INSERM U75, Faculté de Médecine Necker-Enfants Malades, Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Guidez
authors.forename: J L
authors.initials: JL
authors.lastname: Pérignon
authors.forename: A M
authors.initials: AM
authors.lastname: Houllier
authors.forename: N
authors.initials: N
authors.lastname: Balitrand
authors.forename: J P
authors.initials: JP
authors.lastname: Abita
mesh_terms: D002117:Calcitriol / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D003513:Cycloheximide / Q000494:pharmacology; D003564:Cytidine Deaminase / Q000378:metabolism*; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000201:enzymology / Q000473:pathology*; D012176:Retinoids / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013997:Time Factors; D014212:Tretinoin / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: D012176:Retinoids; D014212:Tretinoin; D003513:Cycloheximide; D003564:Cytidine Deaminase; D002117:Calcitriol; D004121:Dimethyl Sulfoxide